Antipsychotic-induced Hyperprolactinemia in aging populations: Prevalence, implications, prevention and management

Clicks: 263
ID: 268367
2020
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #71 of 133 articles by views in progress in neuro-psychopharmacology & biological psychiatry

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 133 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
This paper reviews the prevalence, implications, prevention and management of antipsychotic-induced hyperprolactinemia in aging populations. Antipsychotics are indicated mainly for the treatment of psychotic illness but are also used in other conditions. Complications induced by antipsychotics incre …
Reference Key
a2020progressantipsychotic-induced Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors González-Rodríguez A;Labad J;Seeman MV;;
Journal progress in neuro-psychopharmacology & biological psychiatry
Year 2020
DOI
DOI not found
URL
https://www.pubmed.gov/32243999/
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE review humans pubmed abstract nih national institutes of health national library of medicine research support non-u.s. gov't prevalence prolactin / blood aging / drug effects* disease management* pmid:32243999 doi:10.1016/j.pnpbp.2020.109941 alexandre gonzález-rodríguez javier labad mary v seeman aging / blood antipsychotic agents / adverse effects* dopamine d2 receptor antagonists / adverse effects hyperprolactinemia / blood hyperprolactinemia / chemically induced* hyperprolactinemia / epidemiology* hyperprolactinemia / prevention & control

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.